Advertisement

Mesna Injection

[28 August 2014]

Products Affected - Description

Mesna 100 mg/mL Injection, West-Ward (formerly Bedford product)
10 mL vial, 1 count (NDC 55390-0045-01)
 
Mesna 100 mg/mL Injection, Teva
10 mL vial, 10 count (NDC 00703-4805-03)

Reason for the Shortage

  • Teva has a shortage of mesna injection due to manufacturing delays and does not expect product until late 2015.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired mesna injection from Bedford in July 2014. West-Ward is not actively marketing mesna injection at this time.

Available Products

Mesna 100 mg/mL injection, Fresenius Kabi (formerly APP)
10 mL vial, 1 count (NDC 63323-0773-11)
10 mL vial, 10 count (NDC 63323-0773-10)

Mesna 100 mg/mL Injection, Baxter
10 mL vial, 1 count (NDC 10019-0933-01)
10 mL vial, 10 count (NDC 10019-0933-02)

Mesnex 100 mg/mL Injection, Baxter
10 mL vial, 1 count (NDC 00338-1305-01)
10 mL vial, 10 count (NDC 00338-1305-03)
 
Mesna 100 mg/mL Injection, Mylan Institutional
10 mL vial, 10 count (NDC 67457-0148-10)
 
Mesna 100 mg/mL injection, Sagent
10 mL vials, 1 count (NDC 25021-0201-10)
10 mL vials, 10 count (NDC 25021-0201-11)
10 mL Novaplus vials, 1 count (NDC 25021-0201-66)
10 mL Novaplus vials, 10 count (NDC 25021-0201-67)

Estimated Resupply Dates

  • Teva has mesna injection on back order and the company estimates a release date in the fourth quarter of 2015.
  • West-Ward is not actively marketing mesna injection.

Related Shortages

Updated

August 28, 2014; June 12, 2014; March 27, 2014; January 24, 2014; November 19, 2013; September 18, 2013; July 16, 2013; April 9, 2013; March 13, 2013; February 14, 2013; December 12, 2012; October 11, 2012; September 6, 2012; July 10, 2012; May 9, 2012; April 10, 2012; April 9, 2012; April 4, 2012; March 20, 2012; February 29, 2012; January 18, 2012; December 15, 2011; December 1, 2011; November 11, 2011; November 1, 2011; October 26, 2011; October 19, 2011; October 4, 2011; September 1, 2011; August 26, 2011; July 27, 2011; July 22, 2011; June 23, 2011; June 16, 2011; June 9, 2011; April 13, 2011; March 24, 2011; February 25, 2011; January 6, 2011; December 2, 2010; November 22, 2010; November 8, 2010; September 15, 2010; September 14, 2010; August 4, 2010; July 20, 2010; June 11, 2010; May 28, 2010, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement